tiprankstipranks
Trending News
More News >
Biomarin Pharmaceutical Inc. (DE:BM8)
NASDAQ:BM8
Germany Market

BioMarin Pharmaceutical (BM8) Income Statement

Compare
1 Followers

BioMarin Pharmaceutical Income Statement

Last quarter (Q4 2025), BioMarin Pharmaceutical's total revenue was $874.57M, an increase of 17.03% from the same quarter last year. In Q4, BioMarin Pharmaceutical's net income was $-46.57M. See BioMarin Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.22B$ 2.85B$ 2.42B$ 2.10B$ 1.85B
Gross Profit
$ 2.48B$ 2.27B$ 1.89B$ 1.59B$ 1.38B
Operating Expenses
$ 1.95B$ 1.79B$ 1.70B$ 1.43B$ 1.46B
Depreciation and Amortization
$ 79.56M$ 96.43M$ 104.39M$ 101.97M$ 108.04M
EBITDA
$ 572.94M$ 650.53M$ 306.77M$ 265.36M$ 47.43M
Operating Income
$ 533.48M$ 484.21M$ 185.77M$ 160.97M$ -82.34M
Other Income/Expenses
$ -51.00M$ 57.55M$ 2.79M$ -11.40M$ 6.99M
Pretax Income
$ 482.48M$ 541.76M$ 188.56M$ 149.58M$ -75.35M
Net Income
$ 348.90M$ 426.86M$ 167.65M$ 141.56M$ -64.08M
Per Share Metrics
Basic EPS
$ 1.82$ 2.25$ 0.89$ 0.76$ -0.35
Diluted EPS
$ 1.80$ 2.21$ 0.88$ 0.75$ -0.35
Weighted Average Shares Outstanding
191.79M 190.03M 187.83M 185.27M 182.85M
Weighted Average Shares Outstanding (Diluted)
197.39M 196.71M 191.59M 188.96M 182.85M
Currency in USD

BioMarin Pharmaceutical Earnings and Revenue History